Michael Wiederhorn
Stock Analyst at Oppenheimer
(4.24)
# 514
Out of 4,496 analysts
81
Total ratings
63.48%
Success rate
9.89%
Average return
Main Sectors:
14 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNC Centene | Reiterates: Outperform | $110 | $66.24 | +66.06% | 7 | Jun 21, 2024 | |
| ADUS Addus HomeCare | Maintains: Outperform | $118 → $130 | $118.82 | +9.41% | 8 | Jun 7, 2024 | |
| PACS PACS Group | Maintains: Outperform | $31 → $32 | $32.29 | -0.90% | 2 | May 15, 2024 | |
| ENSG The Ensign Group | Maintains: Outperform | $130 → $135 | $135.47 | -0.35% | 5 | May 6, 2024 | |
| CI Cigna | Maintains: Outperform | $370 → $400 | $335.84 | +19.10% | 4 | May 3, 2024 | |
| HCA HCA Healthcare | Maintains: Outperform | $330 → $345 | $322.16 | +7.09% | 7 | Apr 29, 2024 | |
| TDOC Teladoc Health | Maintains: Outperform | $26 → $21 | $9.09 | +131.02% | 9 | Apr 26, 2024 | |
| HUM Humana | Maintains: Outperform | $415 → $370 | $387.38 | -4.49% | 8 | Apr 25, 2024 | |
| CYH Community Health Systems | Maintains: Outperform | $5.5 → $4.5 | $3.77 | +19.36% | 5 | Apr 25, 2024 | |
| EHAB Enhabit | Maintains: Perform | n/a | $9.49 | - | 2 | Mar 7, 2024 | |
| PNTG The Pennant Group | Maintains: Outperform | $18 → $22 | $27.14 | -18.94% | 4 | Mar 1, 2024 | |
| CHE Chemed | Maintains: Outperform | $625 → $650 | $543.00 | +19.71% | 6 | Feb 29, 2024 | |
| UNH UnitedHealth Group | Reiterates: Outperform | $610 | $565.33 | +7.90% | 10 | Jan 17, 2024 | |
| AMED Amedisys | Maintains: Outperform | $175 → $145 | $97.60 | +48.57% | 4 | Oct 28, 2022 |
Centene
Jun 21, 2024
Reiterates: Outperform
Price Target: $110
Current: $66.24
Upside: +66.06%
Addus HomeCare
Jun 7, 2024
Maintains: Outperform
Price Target: $118 → $130
Current: $118.82
Upside: +9.41%
PACS Group
May 15, 2024
Maintains: Outperform
Price Target: $31 → $32
Current: $32.29
Upside: -0.90%
The Ensign Group
May 6, 2024
Maintains: Outperform
Price Target: $130 → $135
Current: $135.47
Upside: -0.35%
Cigna
May 3, 2024
Maintains: Outperform
Price Target: $370 → $400
Current: $335.84
Upside: +19.10%
HCA Healthcare
Apr 29, 2024
Maintains: Outperform
Price Target: $330 → $345
Current: $322.16
Upside: +7.09%
Teladoc Health
Apr 26, 2024
Maintains: Outperform
Price Target: $26 → $21
Current: $9.09
Upside: +131.02%
Humana
Apr 25, 2024
Maintains: Outperform
Price Target: $415 → $370
Current: $387.38
Upside: -4.49%
Community Health Systems
Apr 25, 2024
Maintains: Outperform
Price Target: $5.5 → $4.5
Current: $3.77
Upside: +19.36%
Enhabit
Mar 7, 2024
Maintains: Perform
Price Target: n/a
Current: $9.49
Upside: -
The Pennant Group
Mar 1, 2024
Maintains: Outperform
Price Target: $18 → $22
Current: $27.14
Upside: -18.94%
Chemed
Feb 29, 2024
Maintains: Outperform
Price Target: $625 → $650
Current: $543.00
Upside: +19.71%
UnitedHealth Group
Jan 17, 2024
Reiterates: Outperform
Price Target: $610
Current: $565.33
Upside: +7.90%
Amedisys
Oct 28, 2022
Maintains: Outperform
Price Target: $175 → $145
Current: $97.60
Upside: +48.57%